Page 8 - Trial Data News Today

A quarter of the dosage given to adults. trial data shows efficacy was below 50% in this particular age group. moderna said the lower dosage was effective. >> about 5,000 children under the age of 6 who received two doses of our covid vaccine and good news is we met the primary endpoints meaning that the vaccine provides the same level of protection against covid in young kids as it does in adults. >> guys, in a matter of minutes now were expecting new york city mayor eric adams to make an annou...

Hospitalizations go up, lives, quite frankly, being lost because of this delay, and we need to get this vaccine licensed appropriately. but again, as you mentioned, we have the safety and efficacy data. we need to get licensed as quickly as possible, not just for hesitancy sake, but i talked to you about this before, because it will allow companies the legal cover to then mandate these vaccines. even the u.s. military has said that they will not mandate this vaccine until its fully licensed. >> ...

Have the safety and efficacy data. we need to get licensed as quickly as possible, not just for hesitancy sake, but i talked to you about this before, because it will allow companies the legal cover to then mandate these vaccines. even the u.s. military has said that they will not mandate this vaccine until its fully licensed. >> strong point. also i heard that getting a booster shot is not really practical until you have the trial data. theyre waiting on that as well. what do you make of what s...

It is imperative that life sciences professionals take account of issues surrounding data handling and technology transfer, in order to effectively maintain and enforce their IP rights

British COVID trial deliberately infecting young adults found to be safe

This first-in-class STAMP inhibitor is approved for use in patients with chronic myeloid leukemia who have developed resistance to tyrosine kinase inhibitors.

Operations and the logistics. so as soon as we have both the fda authorization and the cdc recommendations, there will be vaccine out there, so children can start rolling up their sleeves. >> reporter: 28 million children in the u.s. would be newly eligible. pfizers early trial data showing the vaccine, one-third the adult dose, is nearly 91% effective against symptomatic illness in young children. also reporting zero cases of myocarditis, inflammation of the heart muscle, occurring most often i...

You know, i always thought this was a two-dose vaccine all along. i know the company had hoped that it could serve as a one-dose vaccine from the simple standpoint that globally, you know, it could go much faster and spread among -- and be delivered to many more people globally. so i think their intentions were good. and they actually finally came -- had phase-three trial data for the two doses in september. and it was pretty stunning. its over 90% protection. so i wish it was messaged a little ...

Not really a booster. it turns out this was always a two-dose vaccine. something that weve talked about all year. you know, when we looked at the early phase one, phase-two trial data, it really needed two doses to get consistently high levels of virus neutralizing antibody for everyone. and at that point it was a really, really good vaccine. so there is a subtle difference. with the pfizer vaccine, for instance, theres clear waning, munts, and you need a booster to restore the immunity. with th...

Councilmember conditional said it would not block an extension in december. well talk to senator menendez about where negotiations stand. exclusive reporting from nbc news reveals the u.s. government knew back in july that thousands of haitians were preparing to head to the united states. julia ainsley will discuss the failures that contributed to the humanitarian disaster. we begin this hour with breaking news that pfizer is asking the fda to authorize its covid-19 vaccine for use in children...